Global AI In Clinical Trials Market Growth (Status and Outlook) 2025-2031

The global AI In Clinical Trials market size is predicted to grow from US$ 54.3 million in 2025 to US$ 81.8 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.

The AI in Clinical Trials market is experiencing significant growth and is expected to continue to expand in the coming years. AI, or artificial intelligence, is being increasingly utilized in the field of clinical trials to enhance various aspects of the trial process, including patient recruitment, data analysis, and drug development.

One major trend in the AI in Clinical Trials market is the use of machine learning algorithms to improve patient recruitment and retention. AI algorithms can analyze large amounts of patient data and identify potential candidates for clinical trials more efficiently and accurately than traditional methods. This can help accelerate the recruitment process and ensure that trials have a diverse and representative patient population.

ReportPrime' newest research report, the “AI In Clinical Trials Industry Forecast” looks at past sales and reviews total world AI In Clinical Trials sales in 2024, providing a comprehensive analysis by region and market sector of projected AI In Clinical Trials sales for 2025 through 2031.

This Insight Report provides a comprehensive analysis of the global AI In Clinical Trials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on AI In Clinical Trials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI In Clinical Trials market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI In Clinical Trials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI In Clinical Trials.

This report presents a comprehensive overview, market shares, and growth opportunities of AI In Clinical Trials market by product type, application, key players and key regions and countries.

Segmentation by Type

• Software
• Service

Segmentation by Application

• Pharmaceutical and Biotechnology Companies
• Contract Research Organization
• Other

Market by Region

• Americas
• APAC
• Europe
• Middle East & Africa

Company Coverage

• Intel
• The International Business Machines Corporation(IBM)
• Koninklijke Philips N.V.
• ConcertAl
• Saama Technologies LLC
• Samaa Technologies
• Owkin Inc.
• Numerate
• Neuroute
• AiCure
• Ardigen
• Unlearn Al
• PathAl
• Exscentia
• Aitia Infotech Pvt Ltd.
• Euretos
• VeriSIM Life
• Envisagenics
• NURITAs
• BioSymetrics
• BioAge Labs lInc

Key Questions Addressed in this Report